Eric Holroyd

596 total citations
23 papers, 410 citations indexed

About

Eric Holroyd is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, Eric Holroyd has authored 23 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 5 papers in Hematology. Recurrent topics in Eric Holroyd's work include Acute Myocardial Infarction Research (7 papers), Coronary Interventions and Diagnostics (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Eric Holroyd is often cited by papers focused on Acute Myocardial Infarction Research (7 papers), Coronary Interventions and Diagnostics (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Eric Holroyd collaborates with scholars based in United Kingdom, United States and Croatia. Eric Holroyd's co-authors include Robert D. Simari, Sinny Delacroix, Adriana Harbuzariu, Peter J. Psaltis, Chun Shing Kwok, Mamas A. Mamas, Shuchong Pan, Tyra A. Witt, Cheryl S. Mueske and Robert J. Butler and has published in prestigious journals such as Circulation, Blood and Journal of Neurochemistry.

In The Last Decade

Eric Holroyd

19 papers receiving 404 citations

Peers

Eric Holroyd
Jonathan Lambert United Kingdom
Sophia Chiu United States
Eileen Gillan United States
Carlijn Kuijk Netherlands
Ce Bian China
E Goes Belgium
Eric Holroyd
Citations per year, relative to Eric Holroyd Eric Holroyd (= 1×) peers Maasa Hama

Countries citing papers authored by Eric Holroyd

Since Specialization
Citations

This map shows the geographic impact of Eric Holroyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Holroyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Holroyd more than expected).

Fields of papers citing papers by Eric Holroyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Holroyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Holroyd. The network helps show where Eric Holroyd may publish in the future.

Co-authorship network of co-authors of Eric Holroyd

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Holroyd. A scholar is included among the top collaborators of Eric Holroyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Holroyd. Eric Holroyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwok, Chun Shing, et al.. (2025). The evidence for treatments for postural orthostatic tachycardia syndrome: a systematic review of randomized trials. Trends in Cardiovascular Medicine. 35(8). 517–527.
2.
Kwok, Chun Shing, Josip A. Borovac, Konstantin Schwarz, et al.. (2025). Hospitalizations during the 30-day period preceding admissions with ST-elevation myocardial infarction: Insights from the Nationwide Readmission Database (NRD). International Journal of Cardiology. 423. 132991–132991. 2 indexed citations
3.
Kwok, Chun Shing, Adnan I. Qureshi, Fanna Liu, et al.. (2024). Incidence, predictors and outcomes associated with acute pulmonary embolism in patients hospitalized with pneumonia: Insights from the National Inpatient Sample. Acute Medicine Journal. 23(4). 181–190.
4.
Kwok, Chun Shing, Sadie Bennett, Eric Holroyd, et al.. (2024). Characteristics and outcomes of patients with acute coronary syndrome who present with atypical symptoms: a systematic review, pooled analysis and meta-analysis. Coronary Artery Disease. 36(3). 240–251. 2 indexed citations
5.
Kwok, Chun Shing, Aditya Narain, Homam Moussa Pacha, et al.. (2019). Readmissions to Hospital After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Factors Associated with Readmissions. Cardiovascular revascularization medicine. 21(3). 375–391. 21 indexed citations
6.
Holroyd, Eric, Alex Sirker, Chun Shing Kwok, et al.. (2017). The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes. JACC: Cardiovascular Interventions. 10(13). 1283–1292. 81 indexed citations
7.
Kwok, Chun Shing, William Hulme, Iván Olier, Eric Holroyd, & Mamas A. Mamas. (2016). Review of early hospitalisation after percutaneous coronary intervention. International Journal of Cardiology. 227. 370–377. 25 indexed citations
8.
Wrigley, Benjamin, Eric Holroyd, Andrew Smallwood, et al.. (2016). Vascular endothelial growth factor and hypoxia-inducible factor-1α gene polymorphisms and coronary collateral formation in patients with coronary chronic total occlusions. SAGE Open Medicine. 4. 2103726403–2103726403. 3 indexed citations
9.
Holroyd, Eric, Robert J. Butler, Doug Fraser, et al.. (2015). Transradial Intervention in ST Elevation Myocardial Infarction. Current Cardiology Reports. 17(5). 30–30. 4 indexed citations
10.
Holroyd, Eric, et al.. (2015). Major Bleeding and Adverse Outcome following Percutaneous Coronary Intervention. Interventional Cardiology Reviews Research Resources. 10(1). 22–22.
11.
Holroyd, Eric, et al.. (2015). Transradial percutaneous coronary intervention in high-risk patients. Interventional Cardiology. 7(3). 305–315. 3 indexed citations
12.
Holroyd, Eric, et al.. (2014). Cardiac catheterization. Medicine. 42(8). 468–472.
13.
Holroyd, Eric, Sinny Delacroix, Adriana Harbuzariu, et al.. (2012). Tissue Factor Pathway Inhibitor Blocks Angiogenesis via Its Carboxyl Terminus. Arteriosclerosis Thrombosis and Vascular Biology. 32(3). 704–711. 21 indexed citations
14.
Holroyd, Eric. (2011). Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure. Frontiers in Bioscience-Elite. E4(1). 392–392. 4 indexed citations
15.
Psaltis, Peter J., Adriana Harbuzariu, Sinny Delacroix, et al.. (2011). Identification of a Monocyte-Predisposed Hierarchy of Hematopoietic Progenitor Cells in the Adventitia of Postnatal Murine Aorta. Circulation. 125(4). 592–603. 57 indexed citations
16.
Holroyd, Eric & Robert D. Simari. (2010). Interdependent biological systems, multi-functional molecules: The evolving role of tissue factor pathway inhibitor beyond anti-coagulation. Thrombosis Research. 125. S57–S59. 13 indexed citations
17.
Psaltis, Peter J., Adriana Harbuzariu, Sinny Delacroix, Eric Holroyd, & Robert D. Simari. (2010). Resident Vascular Progenitor Cells—Diverse Origins, Phenotype, and Function. Journal of Cardiovascular Translational Research. 4(2). 161–176. 66 indexed citations
18.
White, Thomas A., Tyra A. Witt, Shuchong Pan, et al.. (2009). Tissue Factor Pathway Inhibitor Overexpression Inhibits Hypoxia-Induced Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 43(1). 35–45. 24 indexed citations
20.
Holroyd, Eric, et al.. (1995). Subcutaneous midazolam, diamorphine and hyoscine infusion in palliative care of a child with neurodegenerative disease. Child Care Health and Development. 21(6). 377–381. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026